TrialAnnals of oncology : official journal of the European Society for Medical Oncology2013

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

A Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.